You are here

Child Neurology Open

Child Neurology Open


eISSN: 2329048X | ISSN: 2329048X | Current volume: 10 | Current issue: 1 Frequency: Yearly

Journal Highlights

  • Indexed In: PubMed Central (PMC) and the Directory of Open Access Journals (DOAJ)
  • Publication is subject to payment of an article processing charge (APC)
  • Submit here


Child Neurology Open (CNO) is a peer-reviewed open access journal which focusses on the most current information from clinical and investigative studies in the wide field of clinical pediatric neuroscience.

This journal is a member of the Committee on Publication Ethics (COPE).


Submission information

Submit your manuscript today at https://mc.manuscriptcentral.com/childneurologyopen. Please see the Submission Guidelines tab for more information on how to submit your article to the journal.


Open access article processing charge (APC) information

Publication in the journal is subject to payment of an article processing charge (APC). The APC serves to support the journal and ensures that articles are freely accessible online in perpetuity under a Creative Commons license.

The APC for CNO is $2000 USD.

The article processing charge (APC) is payable when a manuscript is accepted after peer review, before it is published. The APC is subject to taxes where applicable. Please see further details here.


Contact

Please direct any queries to erin.obrien@sagepub.com

Child Neurology Open (CNO) is an interdisciplinary, peer-reviewed, open access forum for the most current information from clinical and investigative studies in the wide field of clinical pediatric neuroscience. Published articles come from a variety of disciplines, including child neurology, pediatric neurosurgery, pediatric neuroradiology, child and adolescent psychiatry, pediatric neuropsychology, developmental and behavioral pediatrics, and developmental neurobiology. Following careful peer review of submitted material, subsequent acceptance results in very rapid online publication and indexing in the major scientific publication databases.

Advisory Editor
Marc C. Patterson, MD, FRACP Mayo Clinic, Rochester, MN, USA
Editor
Alison Christy, MD, PhD Providence Health and Services, Portland, OR, USA
Associate Editor - Behavioral Neurology
Autumn Ivy, MD, PhD Children’s Hospital of California, University of California - Irvine, CA, USA
Kyle Steinman, MD, MAS Seattle Children's Hospital, Seattle, WA, USA
Associate Editor - Biostatistics
Yinding Wang Centers for Disease Control and Prevention, Atlanta, GA, USA
Associate Editor - Book Reviews
Shawn C. Aylward, MD Nationwide Children's Hospital, Columbus, OH, USA
Associate Editor - Fetal/Neonatal Neuroscience:
Sonika Agarwal, MBBS, MD, DNB, MNAMS Children's Hospital of Philadelphia, Philadelphia, PA, USA
Tally Lerman-Sagie, MD Wolfson Medical Centre, Tel-Aviv University, Tel-Aviv, Israel
Associate Editor – Epilepsy
Angela Curcio, MD Tufts Medical Center, Boston, MA, USA
Aliya Frederick University of California San Diego, San Diego, CA, USA
Inna Hughes University of Rochester Medical Center, Rochester, NY, USA
Laura Kirkpatrick, MD UPMC Children's Hospital of Pittsburgh, University of Pittsburgh, Pittsburgh, PA, USA
Douglas Nordli, MD Childrens Hospital Los Angeles, Los Angeles, CA, USA
Phillip L. Pearl Boston Children’s Hospital, Boston, MA, USA
Associate Editor – Headache
Joanne Kacperski, MD, FAHS Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA
Associate Editors - International
Aviva Fattal-Valevski, MD, MHA Sackler School of Medicine, Tel Aviv University, Tel-Aviv, Israel
Associate Editor - Infections of the Nervous System
Daniel Bonthius, MD, PhD University of Iowa, Iowa City, IA, USA
Associate Editor - Leukodystrophy
Denia Ramirez-Montealegre, MD, MPH, PhD University of Tennessee Medical Center, Knoxville, TN, USA
Associate Editor - Neurodevelopment
Ronald R. Seese, MD, PhD Akron Children’s Hospital, Akron, OH, USA
Associate Editor - Medical Education and Humanities
Associate Editor – MS and demyelinating disorders:
Grace Gombolay, MD Emory University, Atlanta, GA, USA
Jan-Mendelt Tillema, MD Mayo Clinic, Rochester, MN, USA
Associate Editor - Neurohistory
Lawrence A. Zeidman, MD University of Illinois at Chicago, Chicago, IL, USA
Associate Editor – Neuroimaging
Harry T. Chugani, MD New York University, NY, USA
Associate Editor - Neuroimmunology
Geetanjali Rathore, MD Children's Hospital and Medical Center, Omaha, NE, USA
Associate Editor - Neuromuscular Disorders
Anne M. Connolly, MD Washington University School of Medicine, St. Louis, MO, USA
Associate Editor – Neurogenetics
Andrea Gropman, MD Children's National Medical Center, Children's Research Institute, Washington DC, USA
Associate Editor - Neuro-oncology & Neurobiology of Disease
Bernard Maria, MD, MBA Atlantic Health System, Morristown, New Jersey, USA
Associate Editor – Sleep
Suresh Kotagal Mayo Clinic, Rochester, MN, USA
Associate Editor - Stroke and Vascular Neurology
Catherine Amlie-Lefond, MD University of Washington, Seattle, WA, USA
Jenny Wilson, MD Oregon Health Sciences University, Portland, OR, USA
Associate Editor - Special Issues
James W. Wheless, MD The University of Tennessee Health Science Center, Memphis, TN, USA
Director, Residents and Fellows Board
Sonika Agarwal, MBBS, MD, DNB, MNAMS Children's Hospital of Philadelphia, Philadelphia, PA, USA
Editorial Board – Resident/Fellow Section
Richard B. Carozza, MD Vanderbilt Children's Hospital
Eleni Drakou, MD Isabelle Rapin Division of Child Neurology, Saul R. Korey Department of Neurology, Montefiore Medical Center
Whitney Fitts, MD Children's Hospital of Philadelphia, Philadelphia, PA, USA
Mekka Garcia New York University Langone Medical Center, New York, NY, USA
Ariel Heller, MD Medical University of South Carolina, USA
Bianca C. Kapoor-Heaphy, MD Children's Hospital of Philadelphia, Philadelphia, PA, USA
Dennis Keselman, MD Children’s Hospital of Philadelphia, Philadelphia, PA, USA
Laura Kirkpatrick UPMC Children’s Hospital of Pittsburgh, Pittsburgh, PA, USA
Hitoshi Gene Koshiya UPMC Children’s Hospital of Pittsburgh, Pittsburgh, PA, USA
Grant L. Lin, MD, PhD Stanford University, Department of Neurology
Nehali Mehta, MD Children's Hospital of Philadelphia, Philadelphia, PA, USA
Maksim Parfyonov British Columbia Children’s Hospital, Vancouver, BC, Canada
Praveen Kumar Ramani, MD UAMS College of Medicine, Arkansas Children's Hospital
Editorial Board
Pasquale J. Accardo, MD Virginia Commonwealth University Medical Center, Richmond, VA, USA
Guillermo E. Agosta, MD Hospital Italiano de Buenos Aires, Argentina
Leland E. Albright, MD University of Wisconsin - Madison, Madison, WI, USA
Gulay Alper, MD Children's Hospital of Pittsburgh, Pittsburgh, PA, USA
Catherine Amlie-Lefond, MD University of Washington, Seattle, WA, USA
Banu Anlar, MD Hacettepe University, Ankara, Turkey
Ian J. Butler, MD UTHealth McGovern Medical School, Houston, TX, USA
Carol S. Camfield, MD Dalhousie University, Halifax, NS, Canada
Peter R. Camfield, MD, FRCPC Dalhousie University, Halifax, NS, Canada
Eva Catenaccio Johns Hopkins Hospital, Baltimore, MD, USA
Hsiao-Tuan Chao, MD, PhD Baylor College of Medicine, Houston, TX, USA
Keith Coffman, MD Children's Mercy Hospital, Kansas City, MO, USA
Abigail Collins, MD Children's Hospital Colorado, Aurora, CO, USA
Anne Comi, MD Kennedy Krieger Institute, Baltimore, MD, USA
Anne M. Connolly, MD Washington University School of Medicine, St. Louis, MO, USA
Shlomi Constantini, MD, MSc Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel
Patricia K. Crumrine, MD Children's Hospital of Pittsburgh, Pittsburgh, PA, USA
Paolo Curatolo, MD University of Rome Tor Vergata, Rome, Italy
Louis Dang, MD, PhD University of Michigan Health System, Ann Arbor, MI, USA
Danielle de Campo Johns Hopkins Hospital, Baltimore, MD, USA
Emily de los Reyes, MD The Ohio State University, Columbus, OH, USA
Radhika Dhamija, MBBS Mayo Clinic, Phoenix, AZ, USA
Aron J. Diament, MD University of São Paulo, São Paulo, Brazil
Michael M. Dowling, MD, PhD UT Southwestern Medical Center, Dallas, TX, USA
Michael Duchowny, MD Nicklaus Children’s Hospital, Miami, FL, USA
Wendy Edlund Mayo Clinic College of Medicine, Rochester, MN, USA
Kathryn Elkins Emory University School of Medicine, Atlanta, GA, USA
Kevin C. Ess, MD, PhD Vanderbilt University, Nashville, TN, USA
Jason Fangusaro, MD Children's Hospital of Chicago, Chicago, IL, USA
Donna M. Ferriero, MD University of California San Francisco, San Francisco, CA, USA
Francis M. Filloux, MD University of Utah, Salt Lake City, UT, USA
Laura Flores-Sarnat, MD University of Calgary, Calgary, AB, USA
Daniel Freedman Nationwide Children's Hospital, Columbus, OH, USA
Stephen Fulton, MD University of Tennessee Health Science Center, Memphis, TN, USA
Dawn Gano, MD University of California San Francisco, San Francisco, CA, USA
Thomas J. Geller, MD St. Louis University, St. Louis, MO, USA
Amy C. Goldstein, MD Children's Hospital of Philadelphia, Philadelphia, PA, USA
Meredith Golomb, MD Indiana University School of Medicine, Indianapolis, IN, USA
Danielle Gordon UPMC Children’s Hospital of Pittsburgh, Pittsburgh, PA, USA
William Graf, MD Yale University School of Medicine, New Haven, CT, USA
Lorie Hamiwka, MD Seattle Children's Hospital, Seattle, WA, USA
Kenton R. Holden, MD Greenwood Genetic Center, Greenwood, SC, USA
Mackenzie Howard, PhD University of Texas at Austin, Austin, TX, USA
Keith Hyland, PhD Horizon Molecular Medicine, Atlanta, GA, USA
Rebecca Ichord, MD Children's Hospital of Philadelphia, Philadelphia, PA, USA
Katie Ihnen Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA
Christine Imms, MD Australian Catholic University in Melbourne, Australia
Saba Jafarpour Children's Hospital Los Angeles, Los Angeles, CA, USA
Yuwu Jiang, MD, PhD Peking University First Hospital, Beijing, China
Sergiusz Jóžwiak, MD Children's Memorial Health Institute, Warsaw, Poland
Stanley D. Johnsen, MD St. Joseph's Hospital and Medical Center, Phoenix, AZ, USA
Lori Jordan, MD Vanderbilt University Medical Center, Nashville, TN, USA
Makiko Kaga, MD National Center of Neurology and Psychiatry, Tokyo, Japan
Angelina M. Kakooza, MMed Makerere University College, Kampala, Uganda
Edward M. Kaye, MD Stoke Therapeutics, Bedford, MA, USA
Gesina Keating, MD Mayo Clinic, Rochester, MN, USA
Marjolijh Ketelaar, PhD University Medical Center Utrecht, Netherlands
Yasmin Khakoo, MD Memorial Sloan Kettering Cancer Center, New York, NY, USA
Mary Kay Koenig, MD University of Texas Medical School, Houston, TX, USA
Alfried Kohlschütter, MD University Medical Center Hamburg-Eppendorf, Germany
Mark S. Korson, MD Tufts Medical Center, Boston, MA, USA
Barry Kosofsky, MD, PhD Cornell University, New York, NY, USA
Eric Heath Kossoff, MD Johns Hopkins Hospital, Baltimore, MD, USA
Michael Kruer, MD Sioux Falls, South Dakota, USA
Paul D. Larsen, MD University of Nebraska Medical Center, Omaha, NE, USA
Evan Lewis, MD SickKids Hospital - Toronto, Toronto, ON, Canada
Taryn Liu Loma Linda University, Loma Linda, CA, USA
Kenneth J. Mack, MD, PhD Mayo Clinic, Rochester, MN, USA
Annette Majnemer, OT, PhD McGill University, Montréal, QC, Canada
Macpherson Mallewa, MBBS, PhD, MRCP Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi
Elysa Marco, MD University of California - San Francisco, San Francisco, CA, USA
Bernard Maria, MD, MBA Atlantic Health System, Morristown, New Jersey, USA
Harold Marks, MD Drexel University School of Medicine, Philadelphia, PA, USA
Hugh McMillan, MD, DSc University of Ottawa, Ottawa, ON, Canada
Nehali Mehta University of California San Francisco, San Francisco, CA, USA
Douglas C. Miller, MD, PhD University of Missouri, Columbia, MO, USA
Steven P. Miller, MD University of British Columbia, Vancouver, BC, Canada
Jonathan Mink, MD, PhD University of Rochester, Rochester, NY, USA
Mark Mintz, MD The Center for Neurological and Neurodevelopmental Health, Voorhees, NJ, USA
Wendy G. Mitchell, MD Children's Hospital Los Angeles, Los Angeles, CA, USA
Leslie A. Morrison, MD University of New Mexico, Albuquerque, NM, USA
Kathryn North, MD, FRACP Murdoch Children's Research Institute, Melbourne, Australia
Hope O'Brien Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA
Hema Patel, MD Indiana University-Purdue University Indianapolis, IN, USA
John M. Pellock, MD Virginia Commonwealth University, Richmond, VA, USA
Milivoj Velickovic Perat, MD University of Ljubljana, Ljubljana, Slovenia
Danielle Pier, MD MassGeneral Hospital for Children, Boston, MA, USA
Sigita Plioplys, MD Children's Memorial Hospital, Chicago, IL, USA
Deborah L. Renaud Mayo Clinic, Rochester, MN, USA
Wammanda D. Robinson, FWACP Ahmadu Bello University Teaching Hospital, Zaria, Nigeria
Michael Rotstein, MD Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel
Pauline Samia, MPhil Aga Khan University-Nairobi, Kenya
Harvey B. Sarnat, MD Alberta Children's Hospital, Calgary, AB, Canada
G. Bradley Schaefer, MD University of Arkansas, Little Rock, AR, USA
L. Gail Scher, MBBCh, MMed, FCPaeds (SA) Wits University, Johannesburg, South Africa
Benjamin Schindel Johns Hopkins Hospital, Baltimore, MD, USA
Nina Felice Schor, MD, PhD University of Rochester Medical Center, Rochester, NY, USA
Namrata Shah, MD The University of Tennessee Health Science Center, Memphis, TN, USA
Renée Shellhaas University of Michigan Health System, Ann Arbor, MI, USA
Michael Shevell, MD McGill University, Montréal, QC, Canada
Pratibha Singhi, MD Post Graduate Institute of Medical Sciences and Research, Chandigarh, India
John Slopis, MD The University of Texas, MD Anderson Cancer Center, Houston, TX, USA
Steven P. Sparagana, MD Texas Scottish Rite Hospital, Dallas, TX, USA
David Stark, MD Mt. Sinai Hospital, New York, NY, USA
Kyle Steinman, MD, MAS Seattle Children's Hospital, Seattle, WA, USA
Bedirhan Tarhan  
Ann H. Tilton, MD Children's Hospital New Orleans, New Orleans, LA, USA
Alcy R. Torres, MD Boston Medical Center, Boston, MA, USA
Sara Trowbridge Boston Children’s Hospital, Harvard Medical School, MA, USA
Michelle Tutmaher Emory University School of Medicine, Atlanta, GA, USA
Nerija Vaiciene-Magistris, MD Kaunas University of Medicine, Kaunas, Lithuania
Marissa Vawter, MD Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA
Nathan Watemberg, MD Tel-Aviv University, Tel-Aviv, Israel
Mary Anne Whelan, MD, PhD The Mary Imogene Bassett Hospital, Cooperstown, New York, NY, USA
Jo Madeleine Wilmshurst, MB, BS, MRCP, FCP University of Cape Town, South Africa
Elaine C. Wirrell, MD Mayo Clinic, Rochester, MN, USA
Max Wiznitzer, MD Case Western Reserve University, Cleveland, OH, USA
Gordon Worley, MD Duke University, Durham, NC, USA
Joanna Wrede, MD Seattle Children's Hospital, Seattle, WA, USA
Yvonne Wu, MD, MPH University of California, San Francisco, San Francisco, CA, USA
Jo Jo Yang Lucile Packard Children's Hospital Stanford, Palo Alto, CA, USA
  • ProQuest
  • PubMed Central (PMC)
  • This journal has ceased publication and is not accepting new submissions.

    The journal Child Neurology Open (CNO) is an interdisciplinary, peer‐reviewed, open access forum for
    the most current information from clinical and investigative studies in the wide field of clinical pediatric
    neuroscience. Published articles comes from a variety of disciplines, including child neurology, pediatric
    neurosurgery, pediatric neuroradiology, child and adolescent psychiatry, pediatric neuropsychology,
    developmental and behavioral pediatrics, and developmental neurobiology. Following careful peer
    review of submitted material, subsequent acceptance results in very rapid online publication and
    indexing in the major scientific publication databases. Published articles appear on the Sage Journals
    online platform, which helps readers to delve more deeply into the topic of the article through the
    cross‐linking of bibliographies and carefully categorizing articles with related published materials.

    This Journal is a member of the Committee on Publication Ethics.

    This Journal recommends that authors follow the Recommendations for the Conduct, Reporting, Editing,
    and Publication of Scholarly Work in Medical Journals
    formulated by the International Committee of
    Medical Journal Editors (ICMJE).

    Please read the guidelines below then visit the journal’s submission site
    https://mc.manuscriptcentral.com/childneurologyopen to upload your manuscript. Please note that
    manuscripts not conforming to these guidelines may be returned.

    Sage Publishing disseminates high-quality research and engaged scholarship globally, and we are committed to diversity and inclusion in publishing. We encourage submissions from a diverse range of authors from across all countries and backgrounds.

    Only manuscripts of sufficient quality that meet the aims and scope of Child Neurology Open will be
    reviewed.

    As part of the submission process you will be required to warrant that you are submitting your original
    work, that you have the rights in the work, that you are submitting the work for first publication in the
    Journal and that it is not being considered for publication elsewhere and has not already been published
    elsewhere, and that you have obtained and can supply all necessary permissions for the reproduction of
    any copyright works not owned by you.

    If you have any questions about publishing with Sage, please visit the Sage Journal Solutions Portal

    Please note: The APC for CNO is $2000 USD.

    If you have a topic suggestion for a JCN/CNO podcast, please email JChildNeurologyPodcast@gmail.com.

    Please read the Manuscript Submission Guidelines below before submitting your manuscript here: 

    SUBMIT MANUSCRIPT

     

    1. Open Access
    2. Article processing charge (APC)
    3. What do we publish?
      3.1 Aims & scope
      3.2 Article types
      3.3 Writing your paper
      3.3.1 Making your article discoverable 
    4. Editorial policies
      4.1 Peer Review Policy
      4.2 Authorship
      4.3 Acknowledgements
      4.3.1 Writing assistance
      4.4 Funding
      4.5 Declaration of conflicting interests
      4.6 Research ethics and patient consent
      4.7 Clinical Trials
      4.8 Reporting guidelines
      4.9 Data
    5. Publishing policies
      5.1 Publication ethics
      5.1.1 Plagiarism
      5.1.2 Prior publication
      5.2 Contributor's publishing agreement
    6. Preparing your manuscript
      6.1 Word processing formats
      6.2 Artwork, figures and other graphics
      6.3 Supplementary material
      6.4 Reference style
      6.5 English language editing services
    7. Submitting your manuscript
      7.1 How to submit your manuscript
      7.2 Title, keywords and abstracts
      7.3 Information required for completing your submission
      7.4 ORCID
      7.5 Permissions
    8. On acceptance and publication
      8.1 Sage Production
      8.2 Continuous publication
      8.3 Promoting your article
    9. Further information

     

    1. Open Access

    Child Neurology Open is an open access, peer-reviewed journal. Each article accepted by peer review is
    made freely available online immediately upon publication, is published under a Creative Commons
    license and will be hosted online in perpetuity. Publication costs of the journal are covered by the
    collection of article processing charges which are paid by the funder, institution or author of each
    manuscript upon acceptance. There is no charge for submitting a paper to the journal.

    For general information on open access at Sage please visit the Open Access page or view our OpenAccess FAQs.

    Back to top

    2. Article processing charge (APC)

    If, after peer review, your manuscript is accepted for publication, a one-time article processing charge
    (APC) is payable. This APC covers the cost of publication and ensures that your article will be freely
    available online in perpetuity under a Creative Commons license.

    Please note: The APC for CNO $2000 USD.

    The article processing charge (APC) is payable only if your article is accepted after peer review, before it is published. The APC is subject to taxes where applicable. Tax-exempt status can be indicated by providing appropriate registration numbers when payment is requested. Please see further details here.

    3. What do we publish?

    3.1 Aims & scope

    Before submitting your manuscript to Child Neurology Open, please ensure you have read the
    Aims & Scope.

    3.2 Article types

    • Original Research Articles
    • Review Articles/Topical Reviews/Clinical Reviews/State‐of‐the‐Art Reviews Letters
    • Case Reports/Series
      • Case reports should be approximately 1200 words in length and must have an unstructured abstract of approximately 150 words, up to 15 references, and one or two figures and tables. They should be structured for peer review as follows: title page (including title, all authors and affiliations, contact details and keywords), abstract, introduction, case, discussion/conclusion, acknowledgements, funding acknowledgements, declaration of conflict of interest, references, and figure and table legends. Figures and tables should be submitted as separate files.
    • Perspectives

    Child Neurology Perspectives highlight important issues and experiences in child neurology through personal vignettes or opinion essays. Topics can include ethics, research, health policy, public health, medical education and residency, the experience of medicine and the patient-physician relationship.

    Perspectives requirements:
    1.      1500 words or less
    2.      3 authors or fewer
    3.      5 references or fewer
    4.      Patient permission has been obtained or identities are obscured

    • Journal Club

    1.    Papers for our Journal Club must be written by grad students and postdocs. Collaboration is allowed.
    2.    Authors should avoid any possible conflicts of interest, such as an ongoing or previous collaboration with the original authors. 
    3.    Authors must avoid writing an overly critical or complimentary review. Critiques must be thoughtful and well-reasoned.
     
    Structure of a Journal Club paper should include:
     
    Background/summary - This includes a brief overview of the topic, including what question/s the study addresses along with a brief summary of the findings and any controversy that may surround these findings. 
     
    A critique section- This includes critical evaluations of the findings, comparisons or contradictions with other findings, a critique of the methodology,  an alternate interpretation of the paper's findings.
     
    Conclusion- A recap of the paper's main message and significance along with a summary of your main points. 
     
    An explanatory figure is allowed, but must be original and not copied from the reviewed paper.
     
    Please limit your paper to a maximum of 1500 words, not including references. Please avoid unnecessary jargon.
      
    Submitted within 2 months of original article publication

    Authors should avoid conflicts of interest:

    • Not being from the same institution 
    • Not having collaborated with the original authors 
    • Not currently involved in exactly the same area of research
    • Educational Case Reports

    A case report with review of the literature illuminating a learning topic for residents and fellows. These will be reviewed primarily by members of the Residents and Fellows Board.  Approximately 1200 words in length with an unstructured abstract of approximately 150 words; up to 15 references; and one or two figures and tables.

    3.3 Writing your paper

    The Sage Author Gateway has some general advice and on how to get published, plus links to further resources. Sage Author Services also offers authors a variety of ways to improve and enhance their article including English language editing, plagiarism detection, and video abstract and infographic preparation.

    3.3.1 Making your article discoverable 

    When writing up your paper, think about how you can make it discoverable. The title,
    keywords and abstract are key to ensuring readers find your article through search
    engines such as Google. For information and guidance on how best to title your article,
    write your abstract and select your keywords, have a look at this page on the Gateway:
    How to Help Readers Find Your Article Online

    Back to top

    4. Editorial policies

    4.1 Peer review policy

    Following a preliminary triage to eliminate submissions unsuitable for Child Neurology Open all
    papers are sent out for review. The covering letter is important. To help the Editor in his
    preliminary evaluation, please indicate why you think the paper suitable for publication.

    The journal’s policy is to have manuscripts reviewed by two expert reviewers. Child Neurology
    Open utilizes a single-anonymize peer review process in which the reviewer’s name and information is
    withheld from the author. All manuscripts are reviewed as rapidly as possible, while maintaining
    rigor. Reviewers make comments to the author and recommendations to the Editor-in-Chief
    who then makes the final decision.

    The Editor or members of the Editorial Board may occasionally submit their own manuscripts for
    possible publication in the journal. In these cases, the peer review process will be managed by
    alternative members of the Board and the submitting Editor / Board member will have no
    involvement in the decision-making process. 

    Child Neurology Open is committed to delivering high quality, fast peer-review for your paper,
    and as such has partnered with Publons. Publons is a third party service that seeks to track,
    verify and give credit for peer review. Reviewers for Child Neurology Open can opt in to Publons
    in order to claim their reviews or have them automatically verified and added to their reviewer
    profile. Reviewers claiming credit for their review will be associated with the relevant journal,
    but the article name, reviewer’s decision and the content of their review is not published on the
    site. For more information visit the Publons website.

    The Editor or members of the Editorial Board may occasionally submit their own manuscripts for
    possible publication in the journal. In these cases, the peer review process will be managed by
    alternative members of the Board and the submitting Editor/Board member will have no
    involvement in the decision-making process.

    4.2 Authorship

    Papers should only be submitted for consideration once consent is given by all contributing
    authors. Those submitting papers should carefully check that all those whose work contributed
    to the paper are acknowledged as contributing authors.
    The list of authors should include all those who can legitimately claim authorship. This is all
    those who:

    (i) Made a substantial contribution to the concept or design of the work; or acquisition,
    analysis or interpretation of data,
    (ii) Drafted the article or revised it critically for important intellectual content,
    (iii) Approved the version to be published,
    (iv) Each author should have participated sufficiently in the work to take public
    responsibility for appropriate portions of the content.

    Authors should meet the conditions of all of the points above. Each author should have
    participated sufficiently in the work to take public responsibility for appropriate portions of the
    content.

    When a large, multicentre group has conducted the work, the group should identify the
    individuals who accept direct responsibility for the manuscript. These individuals should fully
    meet the criteria for authorship.

    Acquisition of funding, collection of data, or general supervision of the research group alone
    does not constitute authorship, although all contributors who do not meet the criteria for
    authorship should be listed in the Acknowledgments section. Please refer to the International
    Committee of Medical Journal Editors (ICMJE) authorship guidelines
    for more information on
    authorship.

    Please note that AI chatbots, for example ChatGPT, should not be listed as authors. For more information see the policy on Use of ChatGPT and generative AI tools.

    4.3 Acknowledgements

    All contributors who do not meet the criteria for authorship should be listed in an Acknowledgements section. Examples of those who might be acknowledged include a person who provided purely technical help, or a department chair who provided only general support.

    4.3.1 Third party submissions

    Where an individual who is not listed as an author submits a manuscript on behalf of the author(s), a statement must be included in the Acknowledgements section of the manuscript and in the accompanying cover letter. The statements must:

    •    Disclose this type of editorial assistance – including the individual’s name, company and level of input 
    •    Identify any entities that paid for this assistance 
    •    Confirm that the listed authors have authorized the submission of their manuscript via third party and approved any statements or declarations, e.g. conflicting interests, funding, etc.

    Where appropriate, Sage reserves the right to deny consideration to manuscripts submitted by a third party rather than by the authors themselves.

    4.3.2 Writing assistance

    Individuals who provided writing assistance, e.g. from a specialist communications company, do
    not qualify as authors and so should be included in the Acknowledgements section. Authors
    must disclose any writing assistance – including the individual’s name, company and level of
    input – and identify the entity that paid for this assistance.
    It is not necessary to disclose use of language polishing services.

    Any acknowledgements should appear first at the end of your article prior to your Declaration of
    Conflicting Interests (if applicable), any notes and your References.

    4.4 Funding

    Child Neurology Open requires all authors to acknowledge their funding in a consistent fashion
    under a separate heading. Please visit the Funding Acknowledgements page on the Sage
    Journal Author Gateway to confirm the format of the acknowledgment text in the event of
    funding, or state that: This research received no specific grant from any funding agency in the
    public, commercial, or not-for-profit sectors.

    4.5 Declaration of conflicting interests

    It is the policy of Child Neurology Open to require a declaration of conflicting interests from all
    authors enabling a statement to be carried within the paginated pages of all published articles.

    Please include any declaration at the end of your manuscript after any acknowledgements and
    prior to the references, under a heading ‘Declaration of Conflicting Interests’. If no declaration is
    made the following will be printed under this heading in your article: ‘None Declared.’Alternatively,
    you may wish to state that ‘The Author(s) declare(s) that there is no conflict of interest.’

    When making a declaration the disclosure information must be specific and include any financial
    relationship that all authors of the article has with any sponsoring organization and the for‐
    profit interests the organization represents, and with any for‐profit product discussed or implied
    in the text of the article.

    Any commercial or financial involvements that might represent an appearance of a conflict of
    interest need to be additionally disclosed in the covering letter accompanying your article to
    assist the Editor in evaluating whether sufficient disclosure has been made within the
    Declaration of Conflicting Interests provided in the article.

    For guidance on conflict of interest statements, please see the ICMJE recommendations.

    4.6 Research ethics and patient consent

    Medical research involving human subjects must be conducted according to the World Medical
    Association Declaration of Helsinki

    Submitted manuscripts should conform to the ICMJE Recommendations for the Conduct,
    Reporting, Editing, and Publication of Scholarly Work in Medical Journals
    , and all papers
    reporting animal and/or human studies must state in the methods section that the relevant
    Ethics Committee or Institutional Review Board provided (or waived) approval. Please ensure
    that you have provided the full name and institution of the review committee, in addition to the
    approval number.

    For research articles, authors are also required to state in the methods section whether
    participants provided informed consent and whether the consent was written or verbal.

    Information on informed consent to report individual cases or case series should be included in
    the manuscript text. A statement is required regarding whether written informed consent for
    patient information and images to be published was provided by the patient(s) or a legally
    authorized representative. Patients have a right to privacy that should not be infringed without
    informed consent. Identifying information, including patients' names, initials, or hospital
    numbers, should not be published in written descriptions, photographs, and pedigrees unless
    the information is essential for scientific purposes and the patient (or parent or guardian) gives
    written informed consent for publication. Identifying details should be omitted if they are not
    essential. Complete anonymity is difficult to achieve, however, and informed consent should be
    obtained if there is any doubt. For example, masking the eye region in photographs of patients is
    inadequate protection of anonymity. If identifying characteristics are altered to protect
    anonymity, such as in genetic pedigrees, authors should provide assurance that alterations do
    not distort scientific meaning and editors should so note. When informed consent has been
    obtained it should be indicated in the submitted article.

    Please also refer to the ICMJE Recommendations for the Protection of Research Participants.

    All research involving animals submitted for publication must be approved by an ethics committee with oversight of the facility in which the studies were conducted. The Journal has adopted the ARRIVE guidelines.

    In line with the Declaration of Helsinki 1975, revised Hong Kong 1989, we encourage authors to
    register their clinical trials (at http://clinicaltrials.gov or other suitable databases identified by
    the ICMJE). If your trial has been registered, please state this on the Title Page. When reporting
    experiments on animals, indicate on the Title Page which guideline/law on the care and use of
    laboratory animals was followed.

    4.7 Clinical trials

    Child Neurology Open conforms to the ICMJE requirement that clinical trials are registered in a
    WHO-approved public trials registry at or before the time of first patient enrolment as a
    condition of consideration for publication. The trial registry name and URL, and registration
    number must be included at the end of the abstract.

    Child Neurology Open has adopted the proposal from the International Committee of Medical
    Journal Editors (ICMJE) which requires, as a condition of consideration for publication of clinical
    trials, registration in a public trials registry. Trials must register at or before the onset of patient
    enrolment. The clinical trial registration number should be included at the end of the abstract of 
    the article. For this purpose, a clinical trial is defined as any research project that prospectively
    assigns human subjects to intervention or comparison groups to study the cause‐and‐effect
    relationship between a medical intervention and a health outcome. Studies designed for other
    purposes, such as to study pharmacokinetics or major toxicity (e.g. phase I trials), would be
    exempt.

    4.8 Reporting guidelines

    The relevant EQUATOR Network reporting guidelines should be followed depending on the type
    of study. For example, all randomized controlled trials submitted for publication should include
    a completed CONSORT flow chart as a cited figure and the completed CONSORT checklist should
    be uploaded with your submission as a supplementary file. Systematic reviews and metaanalyses
    should include the completed PRISMA flow chart as a cited figure and the completed
    PRISMA checklist should be uploaded with your submission as a supplementary file. The
    EQUATOR wizard can help you identify the appropriate guideline.

    Other resources can be found at NLM’s Research Reporting Guidelines and Initiatives.

    Back to top

    5. Publishing policies

    5.1 Publication ethics

    Sage is committed to upholding the integrity of the academic record. We encourage authors to
    refer to the Committee on Publication Ethics’ International Standards for Authors and view the
    Publication Ethics page on the Sage Author Gateway.

    5.1.1 Plagiarism

    Child Neurology Open and Sage take issues of copyright infringement, plagiarism or other
    breaches of best practice in publication very seriously. We seek to protect the rights of our
    authors and we always investigate claims of plagiarism or misuse of published articles. Equally,
    we seek to protect the reputation of the journal against malpractice. Submitted articles may be
    checked with duplication-checking software. Where an article, for example, is found to have
    plagiarized other work or included third-party copyright material without permission or with
    insufficient acknowledgement, or where the authorship of the article is contested, we reserve
    the right to take action including, but not limited to: publishing an erratum or corrigendum
    (correction); retracting the article; taking up the matter with the head of department or dean of
    the author's institution and/or relevant academic bodies or societies; or taking appropriate legal
    action.

    5.1.2 Prior publication

    If material has been previously published, it is not generally acceptable for publication in a Sage
    journal. However, there are certain circumstances where previously published material can be
    considered for publication. Please refer to the guidance on the Sage Author Gateway or if in
    doubt, contact the Editor at the address given below.

    5.2 Contributor's publishing agreement

    Before publication Sage requires the author as the rights holder to sign a Journal Contributor’s
    Publishing Agreement. Child Neurology Open publishes manuscripts under Creative Commons
    licenses
    . The standard license for the journal is Creative Commons by Attribution NonCommercial
    (CC BY-NC), which allows others to re-use the work without permission as long as
    the work is properly referenced and the use is non-commercial. For more information, you are
    advised to visit Sage's OA licenses page

    Alternative license arrangements are available, for example, to meet particular funder
    mandates, made at the author’s request. 

    Back to top

    6. Preparing your manuscript

    6.1 Word processing formats

    The preferred formats for your manuscript are Word DOC, RTF, XLS. LaTeX files are also
    accepted. Word and (La)Tex templates are available on the Manuscript Submission Guidelines
    page of our Author Gateway. The text should be double‐spaced throughout and with a minimum
    of 3cm for left and right hand margins and 5cm at head and foot. Text should be standard 10 or
    12 point.

    6.2 Artwork, figures and other graphics

    For guidance on the preparation of illustrations, pictures and graphs in electronic format, please
    visit Sage’s Manuscript Submission Guidelines.

    Figures supplied in color will appear in color online. Photographic illustrations should be
    rendered with at least 300 dpi; please use CMYK color conversion if possible. Graphs made with
    Office software such as Microsoft Excel, can be provided in their original format to facilitate
    conversion into printable format with preserved quality. Any other line graphs/illustrations
    should preferably be provided in EPS format with a resolution of at least 600 dpi to prevent
    ragged lines when printed. A figure image should be at least 160 mm in width at the appropriate
    resolution. For further guidance on how to prepare your digital image see
    http://art.cadmus.com/da/index.jsp.

    Graphs and images that are unsuitable may be returned to the author for amendment, causing
    delay in publication.

    6.3 Supplementary material

    This journal is able to host additional materials online (e.g. datasets, podcasts, videos, images
    etc.) alongside the full-text of the article. These will be subjected to peer-review alongside the
    article. For more information please refer to our guidelines on submitting supplementary files,
    which can be found within our Manuscript Submission Guidelines page

    6.4 Reference style

    Child Neurology Open adheres to the AMA reference style. Please review the guidelines on AMA
    to ensure your manuscript conforms to this reference style.

    If you use EndNote to manage references, you can download the AMA output file here.

    6.4.1 Units of Measurement

    Units of measurement should be expressed in SI and metric units; older conventional units may
    be added in parentheses.

    6.4.2 Nomenclature

    Use the generic or chemical name of any drug, in lower case; the specific trade name
    (capitalized) may be given in parentheses after the first text reference.

    6.4.3 Standard abbreviations and symbols

    Standard Abbreviations and symbols should be used, then defined in full in the first instance
    unless they are standard units of measurement. Avoid any use of abbreviations in the article
    title and abstract.

    6.5 English language editing services

    Authors seeking assistance with English language editing, translation, or figure and manuscript
    formatting to fit the journal’s specifications should consider using Sage Language Services. Visit
    Sage Language Services on our Journal Author Gateway for further information. 

    Back to top

    7. Submitting your manuscript

    7.1 How to submit your manuscript

    Child Neurology Open is hosted on Sage Track, a web based online submission and peer review
    system powered by ScholarOne™ Manuscripts. Visit
    https://mc.manuscriptcentral.com/childneurologyopen to login and submit your article online.

    IMPORTANT: Please check whether you already have an account in the system before trying to
    create a new one. If you have reviewed or authored for the journal in the past year it is likely
    that you will have had an account created. For further guidance on submitting your manuscript
    online please visit ScholarOne Online Help.

    7.2 Title, keywords and abstracts

    Please supply a title, short title, an abstract and keywords to accompany your article. The title,
    keywords and abstract are key to ensuring readers find your article online through online search
    engines such as Google. Please refer to the information and guidance on how best to title your 
    article, write your abstract and select your keywords by visiting the Sage Journal Author
    Gateway for guidelines on How to Help Readers Find Your Article Online.

    Keywords: 2‐10 to accompany the abstract. They should, if possible, be drawn from the MeSH
    list of Index Medicus and be chosen with a view to useful cross‐indexing of the article.

    Abstract: The abstract should accurately and concisely reflect the content of the article, and
    should be limited to 150 words. Please avoid reference citations and undefined abbreviations in
    the abstract.

    7.3 Information required for completing your submission

    Provide full contact details for the corresponding author including email, mailing address and
    telephone numbers. Academic affiliations are required for all co-authors. These details should
    be presented separately to the main text of the article to facilitate anonymous peer review.

    You will be asked to provide contact details and academic affiliations for all co-authors via the
    submission system and identify who is to be the corresponding author. These details must
    match what appears on your manuscript. At this stage please ensure you have included all the
    required statements and declarations and uploaded any additional supplementary files
    (including reporting guidelines where relevant).

    7.4 ORCID

    As part of our commitment to ensuring an ethical, transparent and fair peer review process Sage is a supporting member of ORCID, the Open Researcher and Contributor ID. ORCID provides a unique and persistent digital identifier that distinguishes researchers from every other researcher, even those who share the same name, and, through integration in key research workflows such as manuscript and grant submission, supports automated linkages between researchers and their professional activities, ensuring that their work is recognized.

    The collection of ORCID iDs from corresponding authors is now part of the submission process of this journal. If you already have an ORCID iD you will be asked to associate that to your submission during the online submission process. We also strongly encourage all co-authors to link their ORCID ID to their accounts in our online peer review platforms. It takes seconds to do: click the link when prompted, sign into your ORCID account and our systems are automatically updated. Your ORCID iD will become part of your accepted publication’s metadata, making your work attributable to you and only you. Your ORCID iD is published with your article so that fellow researchers reading your work can link to your ORCID profile and from there link to your other publications.

    If you do not already have an ORCID iD please follow this link to create one or visit our ORCID homepage to learn more.

    7.5 Permissions

    Authors are responsible for obtaining permission from copyright holders for reproducing any
    illustrations, tables, figures or lengthy quotations previously published elsewhere. For further
    information including guidance on fair dealing for criticism and review, please visit our
    Frequently Asked Questions on the Sage Journal Author Gateway.

    Back to top

    8. On acceptance and publication

    If your paper is accepted for publication after peer review, you will first be asked to complete the
    contributor’s publishing agreement. Once your manuscript files have been checked for Sage Production,
    the corresponding author will be asked to pay the article processing charge (APC) via a payment link.
    Once the APC has been processed, your article will be prepared for publication and can appear online
    within an average of 30 days. Please note that no production work will occur on your paper until the
    APC has been received.

    8.1 Sage Production

    Your Sage Production Editor will keep you informed as to your article’s progress throughout the
    production process. Proofs will be sent by PDF to the corresponding author and should be
    returned promptly. Authors are reminded to check their proofs carefully to confirm that all
    author information, including names, affiliations, sequence and contact details are correct, and
    that Funding and Conflict of Interest statements, if any, are accurate. 

    8.2 Online publication

    One of the many benefits of publishing your research in an open access journal is the speed to
    publication. With no page count constraints, your article will be published online in a fully
    citable form with a DOI number as soon as it has completed the production process. At this time
    it will be completely free to view and download for all. 

    8.3 Promoting your article

    Publication is not the end of the process! You can help disseminate your paper and ensure it is
    as widely read and cited as possible. The Sage Author Gateway has numerous resources to help
    you promote your work. Visit the Promote Your Article page on the Gateway for tips and advice.

    Back to top

    9. Further information

    Any correspondence, queries or additional requests for information on the Manuscript Submission
    process should be sent to Sage Customer Service

    Back to top